The Autoinjectors Market is expected to witness a growth rate of 14-16% by 2028. The key factors driving the market are the ...

Novo Holdings, a global life sciences investor, today announced its investment in SCHOTT Poonawalla, India's leading provider ...

The desire for patients to have a personalized approach to care is repeated throughout the ad, which was produced by Avalere ...

ANI Pharmaceuticals Inc (ANIP) reports robust growth in generics and cortrophin gel, while addressing market access challenges and sales force turnover.

ANI Pharmaceuticals reports record Q1 2025 growth with strong generics, Cortrophin Gel demand, and raised revenue guidance.

The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...

In February, ANI received U.S. Food and Drug Administration (FDA) approval for a prefilled syringe presentation of Cortrophin Gel. The prefilled syringe provides enhanced convenience by reducing the ...

Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 million to $205.0 million, and adjusted non-GAAP diluted earnings per share ...

Strong financials, 7% sales growth, Vision 2030 focus, & patient-centric innovation with self-injection solutions ...

Reports Strong Q1 2025 Results, Slightly Misses Estimates Argenx SE (NASDAQ:ARGX), a global immunology company, reported ...

Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma ...